Trials / Completed
CompletedNCT03995602
The Effects of Dragon Fruit Consumption on Vascular Function.
A Randomised, Placebo-controlled, Crossover Study of the Effects of Dragon Fruit Effects of Dragon Fruit (Pitaya) Consumption on Vascular Function in Healthy Males and Females
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Native to South America and South East Asia, the dragon fruit (pitaya) has become increasingly popular world-wide due to their vivid hue and bizarre structure. More importantly, their high levels of bioactive phytochemical betalains has sparked considerable scientific interest. Recent findings from in vitro and in vivo animal studies tentatively suggest that betalains may have ameliorative effects on vascular function. This will be a first randomised controlled trial aimed to explore the impact of dragon fruit consumption on blood pressure and other vascular parameters in healthy individuals. The study will feature a randomised, double-blinded, placebo-controlled and crossover design with flow-mediated dilatation (FMD) as primary outcome along with blood pressure and arterial stiffness as secondary outcomes. Cardiovascular biomarkers as well as relevant metabolites will also be determined from blood and urine samples collected from participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dragon fruit juice drink | Dragon fruit drink containing 24 g of freeze-dried dragon fruit powder dissolved in low nitrate water. |
| DIETARY_SUPPLEMENT | Placebo | Drink with macro- and micro-nutrient matched against the intervention drink. |
Timeline
- Start date
- 2019-06-18
- Primary completion
- 2020-01-22
- Completion
- 2020-01-22
- First posted
- 2019-06-24
- Last updated
- 2021-06-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03995602. Inclusion in this directory is not an endorsement.